BMS-986453

A Phase 1, Open-Label, Dose-Finding Study of BMS-986453, Dual Targeting BCMAxGPRC5D Chimeric Antigen Receptor T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma

Arms / Cohorts

Experimental:Part A

Status
Status not available
Treatments
Treatments not available
Criteria
Criteria not available

Accepting patients

Experimental:Part B, Cohort 1

Status
Status not available
Treatments
Treatments not available
Criteria
Criteria not available

Not yet accepting

Experimental:Part B, Cohort 2

Status
Status not available
Treatments
Treatments not available
Criteria
Criteria not available

Not yet accepting

Patient Screener(888) 850-0650

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.